7Q19
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#3) | Descriptor: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | Authors: | Loch, J.I, Barciszewski, J, Pokrywka, K, Lewinski, K. | Deposit date: | 2021-10-18 | Release date: | 2022-05-11 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.55 Å) | Cite: | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
4GNY
| Bovine beta-lactoglobulin complex with dodecyl sulfate | Descriptor: | Beta-lactoglobulin, DODECYL SULFATE, GLYCEROL | Authors: | Gutierrez-Magdaleno, G, Torres-Rivera, A, Garcia-Hernandez, E, Rodriguez-Romero, A. | Deposit date: | 2012-08-17 | Release date: | 2013-02-13 | Last modified: | 2023-09-13 | Method: | X-RAY DIFFRACTION (1.6367 Å) | Cite: | Ligand-binding and self-association cooperativity of beta-lactoglobulin J.Mol.Recognit., 26, 2013
|
|
7Q2P
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#2) | Descriptor: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | Authors: | Loch, J.I, Barciszewski, J, Pokrywka, K, Lewinski, K. | Deposit date: | 2021-10-25 | Release date: | 2022-05-11 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.69 Å) | Cite: | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
5NUK
| Engineered beta-lactoglobulin: variant I56F-L39A-M107F in complex with chlorpromazine (LG-FAF-CLP) | Descriptor: | 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine, Beta-lactoglobulin, CHLORIDE ION, ... | Authors: | Loch, J.I, Bonarek, P, Tworzydlo, M, Lazinska, I, Szydlowska, J, Lewinski, K. | Deposit date: | 2017-04-30 | Release date: | 2018-04-04 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | The engineered beta-lactoglobulin with complementarity to the chlorpromazine chiral conformers. Int. J. Biol. Macromol., 114, 2018
|
|
7Q2N
| Beta-lactoglobulin mutant FAF (I56F/L39A/M107F) in complex with desipramine (FAF-DSM) | Descriptor: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | Authors: | Loch, J.I, Barciszewski, J, Lewinski, K. | Deposit date: | 2021-10-25 | Release date: | 2022-05-11 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
7KOT
| |
7BF9
| |
7Q2O
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#1) | Descriptor: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | Authors: | Loch, J.I, Barciszewski, J, Lewinski, K. | Deposit date: | 2021-10-25 | Release date: | 2022-05-11 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
7Q17
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W), unliganded form | Descriptor: | 1,2-ETHANEDIOL, Beta-lactoglobulin | Authors: | Loch, J.I, Barciszewski, J, Lewinski, K. | Deposit date: | 2021-10-18 | Release date: | 2022-05-11 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
1BEB
| |
7BF8
| |
7Q18
| Beta-lactoglobulin mutant FAF (I56F/L39A/M107F), unliganded form | Descriptor: | Beta-lactoglobulin, SULFATE ION | Authors: | Loch, J.I, Cymborowski, M.T, Minor, W, Lewinski, K. | Deposit date: | 2021-10-18 | Release date: | 2022-05-11 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.804 Å) | Cite: | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
|
|
4KII
| Beta-lactoglobulin in complex with Cp*Rh(III)Cl N,N-di(pyridin-2-yl)dodecanamide | Descriptor: | Beta-lactoglobulin, [N,N-di(pyridin-2-yl-kappaN)dodecanamide]rhodium | Authors: | Cherrier, M.V, Amara, P, Engilberge, S, Fontecilla-Camps, J.C. | Deposit date: | 2013-05-02 | Release date: | 2013-09-04 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (1.85 Å) | Cite: | Structural Basis for Enantioselectivity in the Transfer Hydrogenation of a Ketone Catalyzed by an Artificial Metalloenzyme Eur.J.Inorg.Chem., 21, 2013
|
|
3NQ9
| Bovine beta-lactoglobulin complex with caprylic acid | Descriptor: | Beta-lactoglobulin, CHLORIDE ION, OCTANOIC ACID (CAPRYLIC ACID) | Authors: | Loch, J.I, Lewinski, K. | Deposit date: | 2010-06-29 | Release date: | 2010-07-14 | Last modified: | 2023-11-01 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Two modes of fatty acid binding to bovine beta-lactoglobulin-crystallographic and spectroscopic studies J.Mol.Recognit., 24, 2011
|
|
3NQ3
| Bovine beta-lactoglobulin complex with capric acid | Descriptor: | Beta-lactoglobulin, CHLORIDE ION, DECANOIC ACID, ... | Authors: | Loch, J.I, Lewinski, K. | Deposit date: | 2010-06-29 | Release date: | 2010-07-14 | Last modified: | 2023-11-01 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Two modes of fatty acid binding to bovine beta-lactoglobulin-crystallographic and spectroscopic studies J.Mol.Recognit., 24, 2011
|
|
7BGA
| |
6GHH
| |
3UEV
| |
6T42
| |
5NUN
| Engineered beta-lactoglobulin: variant F105L-L39A-M107F in complex with chlorpromazine (LG-LAF-CLP) | Descriptor: | 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine, Beta-lactoglobulin | Authors: | Loch, J.I, Bonarek, P, Towrzydlo, M, Lazinskia, I, Szydlowska, J, Lewinski, K. | Deposit date: | 2017-04-30 | Release date: | 2018-04-04 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.95 Å) | Cite: | The engineered beta-lactoglobulin with complementarity to the chlorpromazine chiral conformers. Int. J. Biol. Macromol., 114, 2018
|
|
1UZ2
| The Cys121Ser Mutant of Beta-Lactoglobulin | Descriptor: | BETA-LACTOGLOBULIN | Authors: | McNae, I, Jayat, D, Haertle, T, Holt, C, Sawyer, L. | Deposit date: | 2004-03-03 | Release date: | 2004-05-20 | Last modified: | 2023-12-13 | Method: | X-RAY DIFFRACTION (1.95 Å) | Cite: | A recombinant C121S mutant of bovine beta-lactoglobulin is more susceptible to peptic digestion and to denaturation by reducing agents and heating. Biochemistry, 43, 2004
|
|
1B8E
| |
6GFS
| |
6QPD
| |
6QI6
| Trigonal form of WT recombinant bovine beta-lactoglobulin | Descriptor: | 1,2-ETHANEDIOL, Beta-lactoglobulin, ETHANOL | Authors: | Loch, J.I, Krawczyk, A, Lewinski, K. | Deposit date: | 2019-01-17 | Release date: | 2019-01-30 | Last modified: | 2024-01-24 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
|
|